NanoSurface Biomedical awarded $1.9M in new funding from the NIH, bringing total non-dilutive NIH funding awarded to NanoSurface to $3.1M.
Read More
NanoSurface Biomedical announced today the launch of the 384-well NanoSurface Plate™, the newest and highest-throughput offering of the NanoSurface Plates™ product line.
Read MoreNanoSurface Bio announces that its Chief Science Officer, Dr. Nicholas Geisse, will present at Biotech Showcase 2020 held at the Hilton San Francisco Union Square in San Francisco during the JP Morgan Healthcare Conference. The presentation is scheduled for the second day of the event on Tuesday, January 14th at 4:45 PM PT.
Read More
NanoSurface Biomedical announced today that it has acquired Silene Biotech, a Seattle biotechnology company focused on stem cell banking and services. This acquisition expands NanoSurface’s capabilities in developing human stem cell-based platforms and technologies to accelerate the development of new drugs.
Read More
We are in Barcelona, Spain for Safety Pharmacology Society 2019! Visit us at Booth 703 to learn how our biomimetic technologies can mature your cells in an assay- and instrument-agnostic manner!
Read More
We’re in Los Angeles, CA for the International Society for Stem Cell Research 2019! Visit us at Booth 323 to learn how nanotopography and our biomimetic technologies can accelerate your stem cell research!
Read More
Come to our talk (lunch provided!) at World Pharma Week 2019, “Structural Maturation in the Development of hiPSC-Cardiomyocyte Models for Pre-clinical Safety, Efficacy, and Discovery” on Wed, 6/19 at Noon.
Read More
Members of the 4th Industrial Revolution committee from the National Assembly of the Republic of Korea visited NanoSurface Biomedical on May 17, 2019 to learn how the Greater Seattle Area is advancing in STEM and innovation. The National Assembly delegation visited leading Seattle-based companies including Amazon, Boeing, Microsoft, and NanoSurface Biomedical.
Read MoreCome stop by our poster presentation #B273, on Sunday, April 7th between 10 AM - 12 PM EST to learn more about “Enhancing pre-clinical in vitro cardiotoxicity assays with bioengineering strategies in a high-throughput manner.”
Visit Booth 845 to discuss how NanoSurface products can help you produce more physiologically relevant data!
Read More
NanoSurface Biomedical announced today the launch of the NanoSurface Car(ina)™ platform for highly predictive pre-clinical drug screening, using structurally matured human induced pluripotent stem cell (iPSC) derived heart tissues.
Read More
Dr. Nicholas Geisse and Dr. Alec Smith will be giving a technical talk at SOT 2019 titled, “Biomimetic Culture Environments to Enhance In Vitro Assays.” Come attend the talk on Wednesday, March 13, 2019 at 1:30 PM, in Room 338.
Read More
The NanoSurface team will be in Baltimore, MD, March 3-5 for Biophysical Society 2019!
Dr. Ghazizadeh, our Applications Scientist, will be giving a technical talk on "Biomimetic Cell Culture Platforms for Enhancing Cell Biology Studies" on Monday, March 4th, 3:30 PM at Room 303.
Meet us at Booth 505 and learn how mimicking structural (nanotopography), mechanical, and electrochemical cues of the Extracellular Matrix can help you produce more physiologically relevant data.
Read More
The NanoSurface team is at Washington D.C. for SLAS 2019! Come by Booth 1648 during exhibiting hours from February 4 - 6.
Read More
We are very excited to announce our latest distribution partnership with MatTek Corporation, a leader in the life sciences industry!
Read More